Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Patent infarct-related coronary stenting improves left ventricular function
October 25th, 2006
Patients who receive a patent infarct-related artery (IRA) stent after acute myocardial infarction (AMI) demonstrate improved left ventricular function. According to recent research from Taiwan, "This study assesses hemodynamic and angiographic changes in patients with a patent IRA after AMI. One hundred and seventy-seven patients with first AMI who received a predischarge stenting to the IRA and sustained a patent IRA over 3 years, were stratified into 3 groups according to the baseline left ventricular ejection fraction (LVEF): group A included 63 patients with a LVEF of >49%, group B 73 patients with a LVEF of 40-49%, and group C 41 patients with a LVEF of...
Source: Biotech Week (2006-10-25)
|
